UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

Cancer and COVID-19 - potentially deleterious effects of delaying radiotherapy

Nature reviews. Clinical oncology, 2020-06, Vol.17 (6), p.332-334

2020

Link zum Volltext

Verfügbarkeit prüfen

Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database

Journal of thoracic oncology, 2017-02, Vol.12 (2), p.302-313

2017

Link zum Volltext

Verfügbarkeit prüfen

Ductal Carcinoma in Situ in Young Women: Increasing Rates of Mastectomy and Variability in Endocrine Therapy Use

Annals of surgical oncology, 2021-10, Vol.28 (11), p.6083-6096

2021

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum re “Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?” [Eur Urol Open Sci 2020;22:9–16]

European urology open science (Online), 2022-10, Vol.44, p.52-53

2022

Link zum Volltext

Verfügbarkeit prüfen

Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?

European urology open science (Online), 2020-12, Vol.22, p.9-16

2020

Link zum Volltext

Verfügbarkeit prüfen

Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [ 18 F]DCFPyL PET/CT in prostate cancer men

Scientific reports, 2023-05, Vol.13 (1), p.8321-8321, Article 8321

2023

Link zum Volltext

Verfügbarkeit prüfen

Natural history of lower urinary tract symptoms among men undergoing stereotactic body radiation therapy for prostate cancer with and without a Rectal Hydrogel Spacer

World journal of urology, 2022-05, Vol.40 (5), p.1143-1150

2022

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)

BMC cancer, 2023-09, Vol.23 (1), p.1-923, Article 923

2023

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER)

BMC cancer, 2023-08, Vol.23 (1), p.1-781, Article 781

2023

Link zum Volltext

Verfügbarkeit prüfen

Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores

Breast cancer research : BCR, 2018-04, Vol.20 (1), p.26-26, Article 26

2018

Link zum Volltext

Verfügbarkeit prüfen

Use of focal radiotherapy boost for prostate cancer: radiation oncologists' perspectives and perceived barriers to implementation

Radiation oncology (London, England), 2023-11, Vol.18 (1), p.188-188, Article 188

2023

Link zum Volltext

Verfügbarkeit prüfen

68Ga-PSMA-HBED-CC PET/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective single-institutional study

Translational oncology, 2022-01, Vol.15 (1), p.101242, Article 101242

2022

Link zum Volltext

Verfügbarkeit prüfen

166 Radiation Therapy and IRreversible Electroporation (RTIRE) for Intermediate Risk Prostate Cancer

Journal of clinical and translational science, 2024-04, Vol.8 (s1), p.50-50

2024

Link zum Volltext

Verfügbarkeit prüfen

MR-LINAC, a New Partner in Radiation Oncology: Current Landscape

Cancers, 2024-01, Vol.16 (2), p.270

2024

Link zum Volltext

Verfügbarkeit prüfen

Local-Regional Recurrence With and Without Radiation Therapy After Neoadjuvant Chemotherapy and Mastectomy for Clinically Staged T3N0 Breast Cancer

International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (3), p.782-787

2011

Link zum Volltext

Verfügbarkeit prüfen

Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technology

Frontiers in oncology, 2022-09, Vol.12, p.962897

2022

Link zum Volltext

Verfügbarkeit prüfen

Trends in Androgen Deprivation Use in Men With Intermediate-Risk Prostate Cancer Who Underwent Radiation Therapy

Advances in radiation oncology, 2022-07, Vol.7 (4), p.100904-100904, Article 100904

2022

Link zum Volltext

Verfügbarkeit prüfen

Time management: Improving the timing of post-prostatectomy radiotherapy, clinical trials, and knowledge translation

Clinical and translational radiation oncology, 2021-11, Vol.31, p.21-27

2021

Link zum Volltext

Verfügbarkeit prüfen

Smart materials types, properties and applications: A review

Materials today : proceedings, 2020, Vol.28, p.1302-1306

2020

Link zum Volltext

Verfügbarkeit prüfen

Administration of Concurrent Vaginal Brachytherapy During Chemotherapy for Treatment of Endometrial Cancer

International journal of radiation oncology, biology, physics, 2013-11, Vol.87 (4), p.665-669

2013

Link zum Volltext

Verfügbarkeit prüfen

PD20-08 TRENDS IN PROSTATE CANCER SPECIFIC MORTALITY BY RACE OVER TIME: A SEER ANALYSIS

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Link zum Volltext

Verfügbarkeit prüfen

Prostate SBRT Dose Escalation (9 Gy × 5, 13.3 Gy × 3, 24 Gy × 1): Are We Making Progress?

International journal of radiation oncology, biology, physics, 2021-09, Vol.111 (1), p.110-112

2021

Link zum Volltext

Verfügbarkeit prüfen

Challenging the Norm: What Level of Evidence Is Necessary to Adopt Postprostatectomy Hypofractionated Radiation Therapy?

International journal of radiation oncology, biology, physics, 2020-06, Vol.107 (2), p.297-298

2020

Link zum Volltext

Verfügbarkeit prüfen

MP38-17 PROSTATE CANCER GRADE MIGRATION AND FACILITY-LEVEL TREATMENT TRENDS FOR LOW GRADE DISEASE

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Link zum Volltext

Verfügbarkeit prüfen

Radiation therapy and irreversible electroporation for intermediate risk prostate cancer (RTIRE)

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.TPS403-TPS403

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(72)

Publikationsform

Sprache

Englisch
(89)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(42)
Oncology
(34)
Humans
(28)
Male
(17)
Prostate Cancer
(15)
Female
(12)
Radiation Therapy
(12)
Radiology, Nuclear Medicine & Medical Imaging
(11)
Retrospective Studies
(11)
Aged
(10)
Middle Aged
(10)
Aged, 80 And Over
(8)
Magnetic Resonance Imaging
(8)
Radiotherapy
(8)
Adult
(7)
Cancer Therapies
(7)
Care And Treatment
(7)
Patients
(7)
Breast Neoplasms - Pathology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cancer and COVID-19 - potentially deleterious effects of delaying radiotherapy

Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database

Ductal Carcinoma in Situ in Young Women: Increasing Rates of Mastectomy and Variability in Endocrine Therapy Use

Corrigendum re “Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?” [Eur Urol Open Sci 2020;22:9–16]

Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?

Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [ 18 F]DCFPyL PET/CT in prostate cancer men

Natural history of lower urinary tract symptoms among men undergoing stereotactic body radiation therapy for prostate cancer with and without a Rectal Hydrogel Spacer

A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)

Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER)

Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores

Use of focal radiotherapy boost for prostate cancer: radiation oncologists' perspectives and perceived barriers to implementation

68Ga-PSMA-HBED-CC PET/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective single-institutional study

166 Radiation Therapy and IRreversible Electroporation (RTIRE) for Intermediate Risk Prostate Cancer

MR-LINAC, a New Partner in Radiation Oncology: Current Landscape

Local-Regional Recurrence With and Without Radiation Therapy After Neoadjuvant Chemotherapy and Mastectomy for Clinically Staged T3N0 Breast Cancer

Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technology

Trends in Androgen Deprivation Use in Men With Intermediate-Risk Prostate Cancer Who Underwent Radiation Therapy

Time management: Improving the timing of post-prostatectomy radiotherapy, clinical trials, and knowledge translation

Smart materials types, properties and applications: A review

Administration of Concurrent Vaginal Brachytherapy During Chemotherapy for Treatment of Endometrial Cancer

PD20-08 TRENDS IN PROSTATE CANCER SPECIFIC MORTALITY BY RACE OVER TIME: A SEER ANALYSIS

Prostate SBRT Dose Escalation (9 Gy × 5, 13.3 Gy × 3, 24 Gy × 1): Are We Making Progress?

Challenging the Norm: What Level of Evidence Is Necessary to Adopt Postprostatectomy Hypofractionated Radiation Therapy?

MP38-17 PROSTATE CANCER GRADE MIGRATION AND FACILITY-LEVEL TREATMENT TRENDS FOR LOW GRADE DISEASE

Radiation therapy and irreversible electroporation for intermediate risk prostate cancer (RTIRE)

Suchergebnisse filtern